A Cross-sectional Study on the Role of Community Pharmacists in Diabetic Patient Counselling and Health Education Services
DO Shire, PV Ingle, AT Mruthyunjaya… - The Review of …, 2024 - diabeticstudies.org
Background: The purpose of this study was to assess the role of community pharmacists in
patient-centered activities and health education services for patients with type 2 diabetes …
patient-centered activities and health education services for patients with type 2 diabetes …
[PDF][PDF] Current trends in pharmacological treatment of type II diabetes mellitus
PV Ingle, SB Yin, BJ Ying, BK Leong, TZ Xin… - Int J Pharmacol Res …, 2018 - researchgate.net
This review article mainly focusing on the current trends and summary of recent FDA
approved drugs for the treatment of type II diabetes mellitus. From past many years the …
approved drugs for the treatment of type II diabetes mellitus. From past many years the …
Study of lipid lowering effects of oral antidiabetic drugs in type 2 diabetes mellitus patients
E Shashikala, M Somnath, RBNV Raghawa… - International Journal of …, 2018 - go.gale.com
Background: Type 2 diabetes mellitus (T2DM) is one of the most common non-
communicable diseases associated with'atherogenic dyslipidemia'The treatment of T2DM …
communicable diseases associated with'atherogenic dyslipidemia'The treatment of T2DM …
The Impact of Disease Duration on Sex Differences in Cardiometabolic Risk Factors in Type 2 Diabetic Patients on Metformin-glimepiride Oral Therapy
Aims: Patients with type 2 diabetes mellitus (T2DM) are commonly treated with metformin-
glimepiride combination therapy. The relationship between disease duration and …
glimepiride combination therapy. The relationship between disease duration and …
[PDF][PDF] Lipid Lowering Effect of Anti Diabetic Agents-Recent Research
N Pavithra, M Chaitanya - hypertension, 2015 - researchgate.net
Diabetes mellitus type 2 (T2DM) is a multifactorial metabolic disease characterized by
abnormalities at multiple organ sites. In T2DM, the disturbances in lipid profiles, especially …
abnormalities at multiple organ sites. In T2DM, the disturbances in lipid profiles, especially …
Hypolipidemic effect of sitagliptin, voglibose and glimepiride in combination with metformin in patients with type 2 diabetes mellitus at a tertiary care teaching hospital …
Background: The prevalence of coronary artery disease has been increased in diabetic
dyslipidemia; hence the present study would like to compare the dyslipidemic effects of …
dyslipidemia; hence the present study would like to compare the dyslipidemic effects of …
[HTML][HTML] Effect of Lifestyle Modification and Oral Anti-Diabetic Drugs on Metabolic Parameters in Recently Diagnosed Patientswith Uncomplicated Type 2 Diabetes …
N Pradhan, S Das, AK Baliarsinha, A Parhi… - Journal of Diabetes …, 2018 - scirp.org
BACKGROUND: Oral anti-diabetic drugs (OADs) are often advised for initial treatment for
patients with Type 2 Diabetes Mellitus (T2DM). Their effects on glycemic control, lipid profile …
patients with Type 2 Diabetes Mellitus (T2DM). Their effects on glycemic control, lipid profile …
[PDF][PDF] Bacterial Profile and Antibiotic Resistance in Patients with Diabetic Foot Infections in A Tertiary Care Hospital Palakkad
S San, PA Sreeja, BL Swaroop Lal… - Inter. J. Pharma Res …, 2016 - researchgate.net
ABSTRACT BACKGROUND: Foot infections are a major complication of diabetes mellitus
and eventually lead to development of gangrene and lower extremity amputation. Many …
and eventually lead to development of gangrene and lower extremity amputation. Many …
[PDF][PDF] POTENTIALITY OF NEWER ORAL ANTI-HYPERGLYCEMIC COMBINATION THERAPY OVER CONVENTIONAL THERAPY
YHK Reddy, LVPK Reddy - 2015 - wjpr.s3.ap-south-1.amazonaws.com
Background: Antidiabetic agents have an important role in normalizing plasma glucose
levels. Metformin is now recommended as the first agent for blood glucose lowering in type 2 …
levels. Metformin is now recommended as the first agent for blood glucose lowering in type 2 …